Clinical Trials Directory

Trials / Completed

CompletedNCT02506829

Financial Incentives for Smoking Treatment

A Randomized Comparative Effectiveness Trial Of Financial Incentives Versus Usual Care For Smokers Hospitalized In The Veterans Affairs Hospital System

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
182 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators plan to compare the impact of two approaches for smoking cessation on smoking abstinence, use of evidenced-based therapy, and quality of life among a diverse population of patients at the Manhattan campus of the VA New York Harbor Healthcare System, which serves a critical safety-net role for urban veterans. During hospitalization, all smokers will receive usual care. Patients will be randomized to one of two arms: financial incentives plus usual care vs. usual care alone, which includes referral to the state Quitline. All patients enrolled in the study will be offered nicotine replacement therapy. The investigators will conduct follow-up assessments at 2 weeks, 2 months, 6 months and 12 months after discharge. The primary study outcome is smoking abstinence at 6-month follow-up, verified by salivary/urinary cotinine.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSmoking cessation counseling (Quitline)
BEHAVIORALSmoking cessation pharmacotherapy (e.g, nicotine replacement therapy)
BEHAVIORALFinancial incentives

Timeline

Start date
2015-07-01
Primary completion
2019-03-05
Completion
2019-05-20
First posted
2015-07-23
Last updated
2020-12-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02506829. Inclusion in this directory is not an endorsement.